表皮生长因子受体
非小细胞肺癌
癌症研究
无进展生存期
表皮生长因子受体抑制剂
作者
Makoto Maemondo,Tatsuro Fukuhara,Haruhiro Saito,Naoki Furuya,Kana Watanabe,Shunichi Sugawara,Shunichiro Iwasawa,Yoshio Tsunezuka,Ou Yamaguchi,Morihito Okada,Kouzou Yoshimori,Ichiro Nakachi,Akihiko Gemma,Koichi Azuma,Koichi Hagiwara,Toshihiro Nukiwa,Satoshi Morita,Kunihiko Kobayashi
标识
DOI：10.1200/jco.2020.38.15_suppl.9506
摘要
9506Background: In NEJ026, a phase III trial comparing bevacizumab plus erlotinib (BE) to erlotinib monotherapy (E) for EGFR-mutated non-small-cell lung cancer (NSCLC), we demonstrated the progress...
科研通智能强力驱动
Strongly Powered by AbleSci AI
酸化土壤改良
cctv18
个性的紫菜
gjww
SOLOMON
凤凰
shinysparrow
寻寻觅觅呢
紫金大萝卜
benben
壳米
sars518
OG
lalala
maox1aoxin
甜甜玫瑰
可爱迪
宜醉宜游宜睡
yar
阿大呆呆
皖公网安备34019202002308
